Arena Pharmaceuticals, Inc. - ARNA- Profile

Arena Pharmaceuticals, Inc.. The Group's principal activities are to discover, develop and commercialize novel and improve orally available drugs that address major unmet medical needs. The Group develops and commercializes oral drugs in therapeutic areas like cardiovascular, central nervous system, inflammatory and metabolic diseases. The Group has active collaborations with two major pharmaceutical companies, Ortho-McNeil Pharmaceutical Inc, for the treatment of type 2 diabetes and Merck & Co Inc, for the treatment of atherosclerosis and related disorders. The Group has a pipeline of internally discovered small molecule drug candidates that target G protein-coupled receptors ("GPCRs"). The Group operates in the United States. Discovers, develops and commercializes novel and improved orally available drugs